Join 150+ analytical pioneers to discover the realities of working with tools like dPCR, AUC and HPLC, as well as how and where these tools can be most effective in process development, and what the European regulators expect in order to grant approval. Tunisia (+216) File your receipt (which we will email you), record of attendance (which we will provide you at the event) and the completed PIC form with your accounts department which they will submit to IRAS to process the claim. Bermuda (+1441) Drivers of these advances will be discussed including the rapid pace of change from biotechnology, pharmaceutical, manufacturing and CROs with preclinical, non-clinical and trial expertise. Iceland (+354) Ethiopia (+251) The meeting will provide conference attendees updates on recent gene therapy innovations from vector designs to product launch. Terms and conditions apply. Across four days of curated content, incorporating detailed case studies from leading CMC, Regulatory, Analytical and Process Development experts, this is your opportunity to gain a hands-on, practical insight into exactly what it takes to execute successful comparability studies. Hanson Wade's goal is to accelerate progress within organisations and across industries. Saudi Arabia (+966) Gene Therapy for Rare Disorders is dedicated to overcoming the unique drug development challenges encountered in transforming gene therapy concepts into reality for rare disease patients in need. Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Armenia (+374) Kenya (+254) Cameroon (+237) Are You Prepared for the New Digital Reality? Kyrgyzstan (+996) Mexico (+52) If you work in quality control, quality assurance, or process development - weve listened and weve answered. We really enjoyed the partnership opportunity and look forward to see what lasting relationships might develop from the conference. Manager, Business DevelopmentT:781.972.5452jgerardi@healthtech.com, Bethany GrayDirector of Product MarketingT: 781.972.5494bgray@healthtech.com, 250 First Avenue, Suite 300Needham, MA 02494P: 781.972.5400F: 781.972.5425 E:info@hansonwade.com. Why digitization is a must for competitive manufacturing. The Gene Therapy Comparability Summit returns for the second year providing you with all the practical insights to optimize your gene therapy comparability approach. Whether it is learning how to educate and upskill cross-functional teams or tailoring engagement strategies with external HCPs, regulators and patient advocates, join us to determine how best to create a cohesive and streamlined launch strategy specifically for gene therapy products. Whilst Gene Therapies are set to transform treatment paradigms, their complex nature and high price tag presents unique challenges. Latvia (+371) Rwanda (+250) Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. GSK To Equip 12 European Nations For Likely Future Pandemic, 5 Trends In Medical And Orthopedic Devices, MaineHealth Turned COVID-19 Award Into Telehealth Scheme, Three Pharma MSMEs Programmes Launched By Indian Government, Universal Coronavirus Monoclonal Therapy For COVID-19 Strain, Converting Injectable Therapies to Combination Drug-Device Products, Soft mist nasal sprays ready to take the sting out of, Drug shortages and potential solutions to help mitigate them in the, Brazil, India, SA Scientists Seek Speedier Antibiotic Nod, Serum Institute Wins USFDA Approval To Export Novavax Jab, NIH Conducts Clinical Trial of The mRNA Nipah Virus Jab, AES Clean Technology launches OMNI Electric Utility Raceway, Tower Cold Chain Secures Further Investment to Supercharge its, AARDEX Group and BIOCORP Recruited by Trials@Home Decentralized, Novartis signs initial agreement to provide manufacturing capacity for Pfizer-BioNTech COVID-19, DHL Express plays vital role in European Covid-19 vaccine logistics, Baxter BioPharma Solutions Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine, GSK To Equip 12 European Nations For Likely Future, FDA Examines 2 Other Cancer Approvals Without Revocation, NIH Conducts Clinical Trial of The mRNA Nipah Virus, Bharat Biotech Ends Clinical Trial Of Nasal COVID-19 Vaccine, Phesi global analysis of 2.5 million patients finds participants, Calyx Selected by ProTrials as Partner for Improving Clinical, Sharp expands its reach to China through partnership with ClinsChain, Keeping The Risk of Packaging In Check With Kids Involved, Delivering better returns on packaging automation investment, Future Packaging to redefine India Pharm industry growth: InnoPack Pharma Confex, Novartis Victim of Cyberattack But No Sensitive Data Leaked, RCPE and InSilicoTrials to Digitalize and Accelerate the Development, Ashfield Engage acquires smart data organization PROPENSITY4, Subscribe for World Pharma Today E-Magazine, Subscribe for World Pharma Today Magazine Printed Copy. Hong Kong (+852) Martinique (+596) Kazakhstan (+7) Guyana (+592) Hanson Wade's goal is to accelerate progress within organisations and across industries. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. St. Helena (+290) This policy requires individuals to show you proof of vaccination against COVID-19 in order to gain admittance to the conference venue. Zimbabwe (+263). Cuba (+53) The massive success of cell and gene therapies in recent years has made the need for effective, large scale vector engineering greater than ever. Gibraltar (+350) Bosnia Herzegovina (+387) Japan (+81) Investers will have the opportunity to meet with management teams to discuss in detail key therapeutic programs in development nd recent corporate updates. Moldova (+373) E:info@hansonwade.com, Westin Boston Seaport, The Vector Development for Cell and Gene Therapy Summit is North Americas only event focused exclusively on addressing challenges in vector improvement for both ex vivo and in vivo approaches. Jordan (+962) San Marino (+378) For further information around Health and Safety onsite, please visit our FAQs page. By continuing to use this site you consent to the use of cookies, unless disabled from your browser. Both support investment in innovation, productivity and continuous training. Suriname (+597) Have a negative COVID-19 test result from an FDA-authorized over-the-counter antigen test within 24 hours prior to arriving at the event. Argentina (+54) As investment in gene therapies continues to grow rapidly, more effectively engaging patients throughout development has become a priority for any company serious about building safer and more meaningful gene therapy programs. Montserrat (+1664) Nigeria (+234) Canada (+1) Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Togo (+228) Provide proof of full vaccination against COVID-19. View the 2022 event guide to see what you missed. In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety of gene therapy products. Event Organizer: Kisaco Research As the field strives to strike a delicate balance between safety and efficacy, in the context of increased regulatory scrutiny and safety challenges, attending the, This years summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma and academia to continue to, Whether you are focusing on specific characterization methods, enhancing your genome sequencing, advancing your understanding of full and partial particles, or advancing your early-stage bioassays, with 4 tracks, 8 pre-conference workshops and a post-conference focus day, the, Post-Conference Focus Day: Non-AAV Vectors. Gambia (+220) Event Website: https://hubs.ly/Q01c-M4h0 Contact No: +44 (0)20 3696 2920 Netherlands (+31) Gabon (+241) Join Orchard Therapeutics, PTC Therapeutics, Sanofi Genzyme and others as we start to define both the role and value of Medical Affairs from early development of gene therapies right the way to a launch environment. There are however several challenges which needs to be overcome and debated including manufacturing processes, scalability, regulatory compliance, pharmacovigilance & risk management, post-marketing activities, commercialization & market access, and patient evaluation & side-effect management amongst others. For further information around Health and Safety onsite, please visit our FAQs page here or for more information on the B Together Policy, please see here. All of these activities reflect the hope that CGTs will expand the still-limited treatment options available to many patients and transform the clinical paradigm. Virgin Islands - US (+1340) Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. Cancellations received up and including September 18, 2022: full refund less a $80 towards the administrative fee. How to eliminate shop floor errors that cost manufacturers millions. MA, 02210. Hanson Wade's goal is to accelerate progress within organisations and across industries. Eleonora Russo, Director Rare Disease Medical. Denmark (+45) Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. to: Bringing Together Vector Engineers and Scientists to Accelerate Gene Therapy Development. Click here to suggest. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Burundi (+257) By submitting this form you are giving a consent to Worldpharmatoday.com to store your submitted information. Taiwan (+886) Djibouti (+253) This event is tailor-made for Heads, Program Leads, Senior Managers & Executives from across pharmaceutical, biopharmaceutical and biotechnology companies involved in cell & gene therapy developments including the following departments: What are you waiting for? Vice President, Global Regulatory Affairs, Patient Expert & Member of the Committee for Orphan Medicinal Products, Acting Director, Office of Rare Diseases Research, NCATS, Chair of Committee for Orphan Medicinal Products, T: +44 (0)20 3141 8700 Mauritania (+222) Nauru (+674) Laos (+856) Whether you're looking for specific characterisation, potency or infectivity approaches to improve your current analytical toolbox or if you're seeking to understand how gene therapy analytics differ from other biologics you've worked on in the past, this focused, technical event will provide insights specifically on the unique analytical challenges posed by gene therapy vectors, delivered by 'boots on the ground' scientists grappling with these challenges first-hand. As the gene therapy field strives to strike the balance between clinical efficacy and product safety in the context of mounting regulatory scrutiny, View the 2022 event guide to see what you missed. How a digital system can decrease post-production time by 80%. Advancing Gene Therapy 2023 provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners. Italy (+39) Egypt (+20) Outstanding networking. Cambodia (+855) Mozambique (+258) Uzbekistan (+7) 20% Discount 5+ Passes, T: (+1) 617 455 4188 Norway (+47) Ltd., All Rights Reserved. If you are unable to attend the summit at any given time, we will transfer your ticket to next year. Anguilla (+1264) Write CSS OR LESS and hit save. 128 King Henry's Rd, Portugal (+351) This years summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma and academia to continue to develop resilient, long-lasting and robust analytical tools to enhance the safety, quality and efficacy of gene therapy products. In the context of scaling up gene therapy development to achieve commercial goals and mounting regulatory scrutiny, the 2nd Annual Gene Therapy Comparability Summit will unite large pharma and innovative biotechs to ensure you can establish comparability at every stage of development, supporting a seamless transition to the larger scales required for commercialization. Malta (+356) Central African Republic (+236) Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene Therapy Net Gene. Micronesia (+691) Sweden (+46) On May 22, please join us at our Rare Disease Therapeutic Alliance 2023, which will feature 1on1 meetings with the select group of specialty pharma and biotech companies focused on developing therapies for some of the rare and orphan diseases. The rooms are available until March 3rd, 2023. Turks & Caicos Islands (+1649) Thank you. Costa Rica (+506) Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Across four days of curated content, incorporating detailed case studies from leading CMC, Regulatory, Analytical and Process Development experts, The health, safety and well-being of our community remains our highest priority, therefore, all attendees will be required to complete a health declaration prior to attending the event, as well as comply with the City of Bostons B Together policy. It was great to be able to share our perspective with leaders in MA. We use cookies to give you the best experience. Mayotte (+269) strategies, these gene therapeutics are not only life-changing for patients with rare diseases, but are also laying the foundation for potential treatments of other unmet medical needs. Cancellations received between September 19 until January 21, 2023: 50% will be refunded. Uncover the Robust Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products. Comoros (+269) Talks include enhancing the knowledge transfer between departments, bridging between analytical methods with regards to QC/PD, and enhancing in-process development support. Attendees of the Gene Learn from your peers in academia, biotech, CDMOs, CROs, and regulatory organizations and what they are offering. United Arab Emirates (+971) Focused specifically on enhancing your gene therapy comparability approach, this event will ensure you can maintain safety, quality, consistency and efficacy while adapting manufacturing processes, methods and platforms, to satisfy regulatory demands and avoid costly delays to clinical programs. Dominican Republic (+1809) Whether you're working with AAV, non-viral vectors or lentiviral vectors, this is your opportunity to enhance your existing analytical methods and explore innovative new tools to support safe and effective gene therapy development. Crecia Magee, President & Principal Talent Executive, PharmaFinders, T: +1 617 455 4188 Indonesia (+62) Colombia (+57) E:info@hansonwade.com. Our primary method for achieving this is by creating exclusive business conferences that gather together the world's smartest thinkers and doers. Benin (+229) In addition, the summit covers emerging and related fields including Gene Editing & CRISPR, Cell Therapies, Gene Therapy for Cancer, Immunotherapy, Rare diseases, Blood Disorders, Neurological Disorders, Toxicology Studies, advances in manufacturing, regulatory and medical affairs, Commercialization Strategies, Business Models and Market Access. Though R&D efforts focussed on reducing immunogenicity and toxicity whilst improving redosing ability and durability are showing promise, companies are still striving to optimise these technologies and develop next-generation targeted, persistent and tolerable cell and gene therapies. Across three carefully curated days, this streamlined one-track summit will unite key gene therapy leaders from large pharma to ground-breaking biotech, academics to exciting service providers, all with the purpose of paving a way forward to successfully launch gene therapy products in Europe. Email ID: events@kisacoresearch.com. It was great to be able to share our perspective with leaders in MA. Turkmenistan (+7) Tajikstan (+7) Welcome to the 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022, Gain European Regulatory Clarity to Progress Efficient & Robust Gene Therapies for Rare Disease. Tuvalu (+688) Vietnam (+84) Head of Biologics, Biotechnology, and Advanced Therapies, Lead Separation Methods, Gene Therapy Process Development, Head of Gene Therapy Technical Product Development, Vice President, Analytical Chemistry & Site Head Boulder, Senior Manager Field Marketing Centrifugation Europe, T: +44 (0)20 3141 8700 Slovak Republic (+421) Bhutan (+975) Leverage their knowledge and experiences to ultimately ensure effective creation and implementation of patient-centric gene therapy programs. Take the opportunity to meet industry leaders and subject experts; and enhance your network globally through the networking events. Learn how the global leaders of the gene therapy world are transforming the traditional role of medical affairs, from reactive to proactive strategic partners to launch gene therapy products more efficiently and effectively than ever before. Serbia (+381) Potency Assay Development and Validation for Gene Therapy Products, Lyndi Rice, PhDHead, QC Viral Vectors, Biomarin, AAV Capsid Engineering to Increase Human Tissue Tropism and Transduction. Guadeloupe (+590) E: chi@healthtech.com. Botswana (+267) Significant investment is going into this sector. Registration is free and allows users complete access to all sections of the site, including archived news items. Ecuador (+593) * Please note, this is subject to change at any time without prior notice. Cook Islands (+682) France (+33) Guinea - Bissau (+245) Eritrea (+291) Ghana (+233) Bolivia (+591) Chile (+56) This years agenda includes a novel track designed for quality control and process development groups working in gene therapy. CTRL + SPACE for auto-complete. E:info@hansonwade.com, London Marriott Hotel Regents Park Czech Republic (+42) London, Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Palau (+680) #VSBOSTON provides an iconic platform where science, and business converge. Puerto Rico (+1787) Pre-filled Syringes and Injectable Drug Devices - Challenges in Cell & gene therapy, 2nd Multi-Functional Cell Therapies Summit, 2nd TGF- for Immuno-Oncology Drug Development Summit, 5th Antigen-Specific Immune Tolerance Summit - Cell and gene therapy approaches, Formulation & Delivery US: Gene and Cell Therapies, Genetic Vaccine Analytical Development Summit, 5th Annual Gene Therapy for Rare Disorders, 11th Spring Meeting ISBioTech - Viral vectors and vaccines, 10th Neurodegenerative Drug Development Summit, 3rd Gene Therapy for Blood Disorders Summit, 2nd Gene Therapy for Muscular Disorders Summit, Global Bioprocessing Summits - Cell & Gene therapy analytics and manufacturing, ABC-RI International Forum: Spring Edition 2022 - Gene and Cell Therapies for Healthy Ageing, European Society of Gene and Cell Therapy (ESGCT) Spring School, 4th Neuroimmunology Drug Development Summit, SMis 9th Annual Conference Pre-Filled Syringes East Coast - Viral vector deliveries, 3rd Supply Chain and Logistics for Cell Therapies Summit, 5th Neoantigen Summit Europe - T-cell therapies, PEGS Boston Summit - Gene Therapy R&D Analytics, SMis 4th Annual Conference Injectable Drug Delivery - Gene Therapies, Global Bioprocessing Summit Europe - Cell & Gene therapy analytics and manufacturing, American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting, Advanced Therapies (ATMP) Challenges for Routine Applications, PrecisionMed Exhibition and Summit 2022 - Gene Medicines, 2nd Genetic Vaccine Development for Infectious Diseases Summit, ALS Drug Development Summit - Gene & Cell Therapies, 3rd Annual Gene Therapy Analytical Development Europe Summit 2022, 2nd Annual Gene Therapy Patient Engagement Summit, 9th Monolith Summer Symposium Monoliths, Gene Therapy, Vaccines, Next Generation CAR & T Cell Therapies 2022, 2nd Tumor Myeloid-Directed Therapies Summit - Gene and Cell Therapies, 2nd Inner Ear Disorders Therapeutics Summit - Gene Therapies, 1st Rare & Genetic Neurodegenerative Drug Development Summit - Gene Therapies, 3rd TCR-based Therapies for Solid Tumors Summit, 3rd Annual Gene Therapy for Neurological Disorders Europe, BCMA Targeted Therapies - CAR-modified T-cell therapy, 2nd Annual Next Generation Gene Therapy Vectors Summit, 2nd Annual mRNA-Based Therapeutics Summit, iPSC Manufacturing Summit - Gene and Cell therapies, Bioprocessing Summit - Gene and Cell therapies, The Cell Therapy Durability Response Summit, Vector Development for Cell and Gene Therapy Summit, 3rd Annual Gene Therapy for Ophthalmic Disorders, Reuters Events: Cell & Gene Therapy USA 2022, mRNA Process Development & Manufacturing Summit, Oligonucleotide Therapeutics and Delivery 2022, International Human Gene Therapy Conference, Cell & Gene Therapy Manufacturing & Commercialization US, XXIX Congress of the European Society of Gene and Cell Therapy (ESGCT), Global Bioprocessing Summit and Expo - ATMP Development, 3rd Annual Gene Therapy Immunogenicity Summit, Process Development for Cell Therapies Summit, Reuters Events: Oncology at Total Health 2022, 6th Annual Gene Therapy for Rare Disorders Europe Summit 2022, 8th Annual Cell & Gene Therapy Manufacturing Congress, Emerging Non-Coding RNA Therapeutics Summit, Joint meeting of The Australasian Society for Stem Cell Research (ASSCR) and the Australasian Gene and Cell Therapy Society (AGCTS), 4th Annual Gene Therapy Analytical Development, Cell & Gene Therapy Manufacturing & Commercialization Europe, Your conference not listed? Crecia Magee, President & Principal Talent Executive. Copyright 2022 Hanson Wade | Design and site by Event Engine| Hanson Wade Limited is registered in England & Wales, number 06752216. Switzerland (+41) Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH. The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. Seychelles (+248) Email us today at enquiry@equip-global.com! Vector Development for Cell and Gene Therapy Summit 2022. Global Vice President, Technology Development, LogicBio Therapeutics Inc. ", Lots of useful information and good variety of perspectives., Exciting new way of participating in scientific conference and discussion., Incredibly positive and eye-opening experience for a scientist new to the field., Associate Director, Global Patient Advocacy & Engagement, Deputy Director, Officer of Rare Diseases Research, T: +44 (0)20 3141 8700 Antigua & Barbuda (+1268) Venezuela (+58) If you continue to use this site we will assume that you are happy with it. New Caledonia (+687) Dominica (+1809) Spain (+34) Kuwait (+965) Select Country Explore our sponsor or exhibitor packages which offer a wide range of platforms to launch products, gain exposure, collect feedback, network and generate new leads. For more information visit http://www.iras.gov.sg/irashome/picredit.aspx. Be a part of the platform to hear first about the latest news in gene therapy and update your knowledge. Great experience where I learned a lot from experts who were sharing their drive and best practices in the gene therapy MA environment..
Cyclonic Separator Inline, Heavy Duty Industrial Vacuum Cleaner Hire, Industrial Glycol Chiller, 201 75th Ave N, Myrtle Beach, Sc 29572, Aluminum Square Tube Sizes Chart Pdf, Mt Washington Hotel Activities, Micro Pneumatic Cylinder,